CREDELIO QUATTRO DIN 02567520
Health Canada record
| Active ingredient(s) | LOTILANER 450 MG; MOXIDECTIN 0.45 MG; PRAZIQUANTEL 114 MG; PYRANTEL (PYRANTEL PAMOATE) 328.56 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 13-Jul-2026 |
| Current status date | 13-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LOTILANER
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02471205 | CREDELIO | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 56.25 MG | Marketed |
| 02471213 | CREDELIO | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 112.5 MG | Marketed |
| 02471221 | CREDELIO | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 450 MG | Marketed |
| 02471248 | CREDELIO | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 225 MG | Marketed |
| 02471256 | CREDELIO | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 900 MG | Marketed |
| 02526328 | CREDELIO CAT | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 12 MG | Marketed |
| 02526336 | CREDELIO CAT | ELANCO CANADA LIMITED | Tablet (Chewable) | LOTILANER 48 MG | Marketed |
| 02567490 | CREDELIO QUATTRO | ELANCO CANADA LIMITED | Tablet | LOTILANER 56.25 MG; MOXIDECTIN 0.05625 MG; PRAZIQUANTEL 14.25 MG; PYRANTEL (PYRANTEL PAMOATE) 41.07 MG | Marketed |
| 02567504 | CREDELIO QUATTRO | ELANCO CANADA LIMITED | Tablet | LOTILANER 112.5 MG; MOXIDECTIN 0.1125 MG; PRAZIQUANTEL 28.5 MG; PYRANTEL (PYRANTEL PAMOATE) 82.14 MG | Marketed |
| 02567512 | CREDELIO QUATTRO | ELANCO CANADA LIMITED | Tablet | LOTILANER 225 MG; MOXIDECTIN 0.225 MG; PRAZIQUANTEL 57 MG; PYRANTEL (PYRANTEL PAMOATE) 164.28 MG | Marketed |
| 02567539 | CREDELIO QUATTRO | ELANCO CANADA LIMITED | Tablet | LOTILANER 900 MG; MOXIDECTIN 0.9 MG; PRAZIQUANTEL 228 MG; PYRANTEL (PYRANTEL PAMOATE) 657.12 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37324 | 2026-04-15 | New Drug Submission (NDS) |
International API supply for LOTILANER
1 active FDA Drug Master Files.
Request a quote for CREDELIO QUATTRO